They reported strong E-cadherin expression in more than 50% of liver, brain, and lung metastasis originating from infiltrating ductal carcinoma of the breast, as well as in lung metastases from E-cadherin-negative MDA-MB-231 primary xenografts. This evidence concerns the gene CDH1 and invasive ductal breast carcinoma.